NCT05496686 2026-04-03
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
Modulation Therapeutics, Inc.
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT03467516 2025-07-10
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
University of Pittsburgh
Phase 2 Recruiting
NCT01785316 2024-01-26
SCANDIUM
Vastra Gotaland Region
Phase 3 Completed
NCT00406120 2018-06-26
Validation of a Molecular Prognostic Test for Eye Melanoma
Washington University School of Medicine
Withdrawn